CX 2018: Podium 1st presentations

In addition to the plethora of late-breaking trials that were unveiled at this year’s Symposium, there was a vast array of Podium 1st presentations. These presentations showcased novel techniques and technologies, provided further insights into the safety and effectiveness of established devices, and highlighted potential solutions to current challenges in the management of vascular disease.

Peripheral Ischaemia Controversies

Randomised controlled trial at one year – paclitaxel-eluting stent vs. bare metal stent
Speaker: Yann Gouëffic, Nantes, France

BIOLUX P-III
Speaker: Gunnar Tepe, Bad Rosenheim, Germany

Effectiveness of paclitaxel-coated balloon catheter vs. uncoated balloon catheter in the SFA and PA to prevent restenosis or reocclusion – 12-month data
Speaker: Ulf Teichgraeber, Jena, Germany

Below-the-knee dedicated sirolimus-eluting stent
Speaker: Kim Taeymans, Antwerp, Belgium

Venous Controversies

The EVRA trial
Faculty: Manj Gohel, Cambridge, United Kingdom
Francine Heatley, London, United Kingdom
Alun Davies, London, United Kingdom
David Epstein, Granada, Spain

Abdominal Aortic Controversies

Risk of abdominal aortic aneurysm among male and female relatives of abdominal aortic aneurysm patients
Speaker: Hence Verhagen, Rottendam, Netherlands

Aneurysm rupture risk stratification with use of real time 3D speckle tracking ultrasound and finite element analysis
Speaker: Thomas Schmitz-Rixen, President, DGG, Frankfurt, Germany

EVAS is associated with a reduction in all-cause mortality
Speaker: Marc Schermerhorn, Boston, United States